The Technical Analyst
Healthwell Acquisition [HWEL]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
Healthwell Acquisition Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.05% $10.48
America/New_York / 28 nov 2023 @ 12:38
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 327.34 mill |
| EPS: | 0.370 |
| P/E: | 28.31 |
| Earnings Date: | Dec 30, 2022 |
| SharesOutstanding: | 31.25 mill |
| Avg Daily Volume: | 0.0376 mill |
| RATING 2023-12-13 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 28.31 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 28.31 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.30 - 10.64 ( +/- 1.65%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-07-21 | Healthwell Acquisition Corp. I Sponsor Llc | Buy | 6 249 999 | Class A Common Stock |
| 2023-07-21 | Healthwell Acquisition Corp. I Sponsor Llc | Sell | 6 249 999 | Class B Common Stock |
| 2021-09-16 | Maccarthy John L | Sell | 937 500 | Class B common stock |
| 2021-09-16 | Healthwell Acquisition Corp. I Sponsor Llc | Sell | 937 500 | Class B common stock |
| 2021-09-16 | Rapp Alyssa | Sell | 937 500 | Class B common stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 7 transactions |
| Buy: 6 249 999 | Sell: 16 249 999 |
Forecast:
01:40 - $10.42
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.48 (0.05% ) |
| Volume | 0.0011 mill |
| Avg. Vol. | 0.0376 mill |
| % of Avg. Vol | 2.95 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HWEL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HWEL
Healthwell Acquisition Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire technology-enabled companies in the healthcare industry. The company was incorporated in 2021 and is based in Winnetka, Illinois.
Last 10 Buy Signals
Latest Press Releases
2023-11-17 21:29:00 - Press Release
Healthwell Acquisition Corp. I Announces Cancellation Of Special Stockholder Meeting And Its Intention To Liquidate
Winnetka, ill.--(business wire)--healthwell acquisition corp. i (“healthwell”) (nasdaq: hwel) announced today that (i) its previously announced special meeting of stockholders that was scheduled for december 4, 2023 has been cancelled, and that it has withdrawn from consideration by healthwell's stockholders the proposals set forth in heatlhwell's definitive proxy statement on schedule 14a filed with the u.s. securities and exchange commission (the “sec”) on november 13, 2023 and (ii) it intend.
2023-11-03 19:00:00 - Press Release
Healthwell Acquisition Corp. I Announces Termination Of Business Combination With Starton Therapeutics, Inc.
Winnetka, ill.--(business wire)--healthwell acquisition corp. i (“healthwell”) (nasdaq: hwel) announced today that its previously announced business combination agreement in connection with its planned business combination with starton therapeutics, inc. (“starton”) was terminated by starton. the conditions to the closing of the initial business combination were not satisfied or waived by the outside date of november 3, 2023. as a result, healthwell will seek an alternative business combination.
2023-11-03 18:00:00 - Press Release
Starton Therapeutics Announces Termination Of Business Combination Agreement With Healthwell Acquisition Corp. I
Paramus, n.j.--(business wire)--starton therapeutics inc. (“starton” or “the company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified healthwell acquisition corp. i (nasdaq: hwel) (“healthwell”) today that the company had elected to terminate the business combination agreement among starton, healthwell and the other parties thereto dated as of april 27, 2023, as amended (the “.
2023-10-23 23:55:00 - Press Release
Healthwell Acquisition Corp. I Announces Postponement Of The Special Meeting Of Stockholders To Approve The Proposed Business Combination With Starton Therapeutics, Inc. And Related Transactions
Paramus, n.j. & winnetka, ill.--(business wire)--healthwell acquisition corp. i (“healthwell,” “hwel” or the “company”) (nasdaq: hwel) announced today that it has postponed until further announcement the date of the special meeting of the company's stockholders (the “meeting”) to approve its proposed business combination with starton therapeutics, inc. (“starton”) and related transactions that had been scheduled for 10:00 a.m. eastern time on october 25, 2023. at the meeting, the stockholders w.
2023-10-17 06:00:00 - Press Release
Healthwell Acquisition Corp. I Announces New Meeting Date For The Special Meeting Of Stockholders To Approve Proposed Business Combination With Starton Therapeutics, Inc. And Related Transactions
Paramus, n.j. & winnetka, ill.--(business wire)--healthwell acquisition corp. i (“healthwell,” “hwel” or the “company”) (nasdaq: hwel) announced today that it has postponed the date of the special meeting of the company's stockholders (the “meeting”) to approve its proposed business combination with starton therapeutics, inc. (“starton”) and related transactions from the originally scheduled date of october 19, 2023. the new meeting time and date will be 10:00 a.m. eastern time on october 25, 2.